Previous studies shown that abnormal inflammasome and monocyte activation play a pathogenic role in the development of dengue, supported by evidence based on clinical samples in which IL-18, LBP and sCD14 are elevated in patients with severe dengue (49). This evidence concerns the gene LBP and dengue disease.